Greater Richmond Region
Award-winning oncology regional sales director and sales professional with more than twenty years of oncology industry experience.
Responsible for hiring and leading a team of uro oncology area managers for the Atlantic Coast region. Region included Delaware, Maryland, DC, Virginia, North Carolina, and South Carolina. Maintain productive relationships with a broad base of urologic oncologists, urologists, radiation oncologists, and medical oncologists • Hired and led team to launch novel oral GnRH antagonist for advanced prostate cancer • Passionately focused on employee development - in process of developing 2 team members toward internal promotions • Effectively executed pull through strategies in a competitive and dynamic oral therapy product access environment (specialty pharmacy, GPOs, self-dispense networks, pathway programs) • Recognized for maximizing cross-functional partnerships across market access, sales operations, and medical teams • Maintained back-to-back sales excellence across the team • Retained entire team throughout challenging launch Management Sales Achievements • 2022 Region Ranked 3rd in the Nation • 2022 Recipient, Spirit of Myovant Award • 2021 Recipient, Circle of Excellence – Region Ranked 2nd in the Nation • 2021 Recipient, Spirit of Myovant Award
Responsible for leading a team of area managers and regional oncology managers across 2 regions (formerly DC, Richmond, West Virginia, Columbus, and Cincinnati markets. Currently aligned to Richmond, Carolinas, and Georgia markets). Maintain productive relationships with a broad base of gynecologic oncologists and medical oncologists • Led team through GSK acquisition with no attrition in 2019; hired six team members in 2020 • Developed 2 team members toward internal promotions • Coordinated corporate leadership visits to key accounts including University of Virginia, Ohio State University, Virginia Cancer Specialists, and other large community accounts • Effectively execute pull through strategies in a dynamic oral therapy product access environment (specialty pharmacy, GPOs, self-dispense networks, pathway programs) • Recognized for maximizing cross-functional partnerships across pharmacy and business operations, strategic engagement, nurse educator, market access, and medical teams • Nominated by team for National Essence Award, an award recognizing individuals exemplifying Tesaro Mission and Values Management Sales Achievements • Inherited a team ranked 14th out of 14; Led team to top 50% within 2 quarters • 2019 #2 Region in Nation • 2019 Performance Rating: Outstanding Results/Outstanding Behavior • 2019 Performance Circle
Selected as part of an expansion team to launch novel PARP inhibitor for the treatment of recurrent ovarian cancer and a NK-1 receptor antagonist for delayed CINV. Responsible for working closely with cross-functional partners including health systems manager, oncology nurse educator, provider solutions manager, and GPO account managers to drive business with gynecologic and medical oncologists. • Ranked #6 in nation Q1 Zejula launch; • Led region with top prescribing accounts with Zejula and Varubi Q1, Q2 • Nominated and selected to serve on 2017-2018 inaugural sales advisory council
Selected as one of 60 representatives to launch first-in-class androgen receptor signaling inhibitor for the treatment of metastatic castrate-resistant prostate cancer. Responsible for working closely with territory counterparts, market access colleagues, and cross-functional teams to drive business with oncologists and urologists. • Ranked #2 in nation 2013; Q1 launch 1,079% PTP ; Launched to KTL who became top prescriber in the nation • Ranked #3 in nation in market share (67%) 2014 • Consistently had top volume territory in division throughout tenure • Top urology volume territory in the nation PTD 2015 • Developed 4 KTLs into national speakers • Facilitated several meetings between KTLs and corporate colleagues (CEO, CCO, and marketing) • Nominated and selected by sales leadership to serve on 2015 and 2016 XTRA sales advisory team - acting as liaison between corporate and the field • Nominated for regional core value award 2015 • Selected to serve on field advisory team for new e-detailing piece • Selected to mentor 30 new hires at training class at corporate headquarters 2014 • Selected to mentor new hires during 2016 sales expansion • Routinely facilitate area meetings
Selected as one of 30 representatives to launch first-in-class active-cellular immunotherapy for the treatment of metastastic castrate-resistant prostate cancer. Launched to key thought leaders in academic and high-volume community settings throughout the Virginia, DC, and Maryland area. Responsible for working closely with market access, medical, and apheresis partners to drive business with oncologists and urologists. • Nominated and selected by sales leadership to represent southeast region on 2012 Brand Council team - acting as liaison between corporate and the field • 2011 YTD Quota Attainment at 126% (no individual quotas in 2010) • Ranked 3rd in nation for number of actively-infusing accounts • Selected to mentor 4 new representatives when expansion occurred • Selected to participate in market research study detailing new clinical sales aids to both urologists and oncologists • Developed ISS Provenge process guideline presentation which was introduced to multiple divisions across the country
Promoted to newly-created district specialty position. Responsible for promoting an agent spanning 9 indications to key thought leaders in academic and high-volume community settings throughout the district. Responsible for working closely with territory counterparts, regional and district managers, and cross-functional teams to ensure successful execution of tactics. • Ranked #1 in Region and #2 in Nation, National Sales Award Winner, FY2007 • Recipient of ODAB, oncology deferred annual bonus, an award to retain top talent • Selected to serve as group sales leader at oncology training class at national headquarters (2009) and regional training classes periodically • Selected to represent southeast region on LINC (Leadership in Communication) team - acting as liaison between corporate and the field 2010 • Routinely selected to represent the company at San Antonio Breast Cancer Conference and American Society of Clinical Oncologists meetings